,
Somé, Eric N.
Engebretsen, Ingunn M. S.
Nagot, Nicolas
Meda, Nicolas
Lombard, Carl
Vallo, Roselyne
Peries, Marianne
Kankasa, Chipepo
Tumwine, James K.
Hofmeyr, G. Justus
Singata, Mandisa
Harper, Kim
Van De Perre, Philippe
Tylleskar, Thorkild
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (CT.2006.33020.004)
Inserm–ANRS (ANRS12174)
GlobVac (18360)
the Norwegian Quota scheme program (2710641)